Liver fibrosis is the only predictor of adverse outcomes: time to remove metabolic dysfunction associated steatohepatitis (MASH) resolution as a clinical trial endpoint

Younossi Z. M., Yu M., de Avila L., Petta S., Hagstrom H., Kim S. U., ...More

JOURNAL OF HEPATOLOGY, vol.84, 2026 (SCI-Expanded, Scopus)

  • Publication Type: Article / Abstract
  • Volume: 84
  • Publication Date: 2026
  • Journal Name: JOURNAL OF HEPATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Recep Tayyip Erdoğan University Affiliated: No